There are 85 papers on brain natriuretic peptide in aging research: 11 trials and 49 observational studies in people, 13 in animals, 1 in cells, 7 reviews.
85 papers study it160 more mention it24 findings
10 new papers in 30 daysSee all 245 papers on brain natriuretic peptide
“Significant depressive symptoms were associated with Log BNP levels (β=0.56, P = 0.02).”
- Human trial11
- Humans49
- Animals13
- Cells1
- In silico1
Interventions
3Cardiac rehabilitation
downin humans1
1 study
Cardiac rehabilitation
downin humans1
Cardiac rehabilitation is linked with lower brain natriuretic peptide in HFrEF patients with CKD (688 vs 488 pg/mL, P < .001).
Humansin HFrEF patients with CKD4-wkn = 567
Baduanjin
no changein humans1
1 study
Baduanjin
no changein humans1
Baduanjin showed no clear effect on brain natriuretic peptide in humans (chronic heart failure).
Human trialchronic heart failure12 weeksn = 103
SGLT2 inhibitors
downin humans1
1 study
SGLT2 inhibitors
downin humans1
SGLT2 inhibitors are linked with lower brain natriuretic peptide in patients with brain natriuretic peptide above the upper limit before treatment.
Humansin patients with brain natriuretic peptide above the upper limit before treatment6 monthsn = 78
Effects
1Mortality
no changein humans1
1 study
Mortality
no changein humans1
Brain natriuretic peptide was not clearly linked with mortality in humans (hip fracture surgery, primary multivariate logistic regression analysis) (p = 0.081).
Humanship fracture surgery, primary multivariate logistic regression analysis90-dayn = 133
Associations
15Mortality
upin humans6HR 1.26–1.44
6 studies
Mortality
upin humans6HR 1.26–1.44
Brain natriuretic peptide is associated with mortality in humans (hospitalized Japanese older patients with a risk of infection) (HR 1.26 (0.89-1.76)).
Humanshospitalized Japanese older patients with a risk of infection30 days
Brain natriuretic peptide predicts mortality in patients with heart failure and sarcopenia.
Humansin patients with heart failure and sarcopenia
Brain natriuretic peptide is linked with a higher risk of mortality in humans (hypertension without symptoms of heart failure) (HR 1.44, 95% CI 1.07 to 1.94).
Humanshypertension without symptoms of heart failureup to 9 yearsn = 530
Brain natriuretic peptide is associated with mortality in humans (hip fracture surgery) (p = 0.038).
Humanship fracture surgery90-dayn = 133
Brain natriuretic peptide predicts mortality in humans (surgically treated hip fractures).
Humanssurgically treated hip fractures2 yearsn = 455
Brain natriuretic peptide predicts mortality in humans (proximal femur fracture).
Humansproximal femur fracturen = 112
Incident atrial fibrillation
upin humans1
1 study
Incident atrial fibrillation
upin humans1
Brain natriuretic peptide predicts incident atrial fibrillation in humans (Prospective studies measuring BNP prior to onset).
ReviewProspective studies measuring BNP prior to onset
Atrial fibrillation
upin humans1
1 study
Atrial fibrillation
upin humans1
Brain natriuretic peptide is associated with atrial fibrillation in humans (Prevalent atrial fibrillation) (Pooled standardized mean difference 1.08; 95% CI 0.67–1.49; P < 0.0001).
ReviewPrevalent atrial fibrillation
Single-lead electrocardiography
upin silico1
1 study
Single-lead electrocardiography
upin silico1
Single-lead electrocardiography predicts brain natriuretic peptide in silico (testing dataset) (macro-average AUC 0.87 ± 0.03).
In silicotesting datasetn = 105,712
Third lumbar level psoas muscle index
downin humans1
1 study
Third lumbar level psoas muscle index
downin humans1
Third lumbar level psoas muscle index is associated with brain natriuretic peptide in humans (patients waitlisted for kidney transplant) (P < .01).
Humanspatients waitlisted for kidney transplantn = 172
Acylcarnitines
upin humans1
1 study
Acylcarnitines
upin humans1
Brain natriuretic peptide is associated with acylcarnitines in humans (patients who underwent surgery for cardiovascular diseases) (β = 0.273, p = 0.011).
Humanspatients who underwent surgery for cardiovascular diseasesserumn = 117
Depressive symptoms
upin humans1
1 study
Depressive symptoms
upin humans1
Depressive symptoms are associated with brain natriuretic peptide in humans (significant depressive symptoms) (β=0.56, P = 0.02).
Humanssignificant depressive symptomsn = 1,432
Heart failure
upin humans1HR 3.88
1 study
Heart failure
upin humans1HR 3.88
Brain natriuretic peptide is linked with a higher risk of heart failure in humans (hypertension without symptoms of heart failure) (HR 3.88, 95% CI 2.13 to 7.10).
Humanshypertension without symptoms of heart failureup to 9 yearsn = 530
Cardiovascular disease
upin humans1HR 1.45
1 study
Cardiovascular disease
upin humans1HR 1.45
Brain natriuretic peptide is linked with a higher risk of cardiovascular disease in humans (hypertension without symptoms of heart failure) (HR 1.45, 95% CI 1.15 to 1.82).
Humanshypertension without symptoms of heart failureup to 9 yearsn = 530
Postoperative complications
upin humans1
1 study
Postoperative complications
upin humans1
Brain natriuretic peptide predicts postoperative complications in humans (surgically treated hip fractures).
Humanssurgically treated hip fractures2 yearsn = 455
All 15Fewer
Funding
1 grant since 2024National Heart, Lung, and Blood Institute$1M